Capital Asset Advisory Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $402K | Buy |
5,620
+212
| +4% | +$15.2K | 0.02% | 193 |
|
|
2025
Q1 | $391K | Sell |
5,408
-1,068
| -16% | -$77.1K | 0.02% | 194 |
|
|
2024
Q4 | $429K | Buy |
6,476
+100
| +2% | +$6.63K | 0.02% | 199 |
|
|
2024
Q3 | $490K | Sell |
6,376
-325
| -5% | -$25K | 0.02% | 187 |
|
|
2024
Q2 | $514K | Buy |
6,701
+1,741
| +35% | +$133K | 0.03% | 181 |
|
|
2024
Q1 | $335K | Sell |
4,960
-378
| -7% | -$25.5K | 0.02% | 230 |
|
|
2023
Q4 | $360K | Sell |
5,338
-35
| -0.7% | -$2.36K | 0.02% | 222 |
|
|
2023
Q3 | $365K | Buy |
5,373
+626
| +13% | +$42.6K | 0.03% | 224 |
|
|
2023
Q2 | $320K | Sell |
4,747
-781
| -14% | -$52.6K | 0.02% | 247 |
|
|
2023
Q1 | $384K | Buy |
5,528
+60
| +1% | +$4.17K | 0.03% | 228 |
|
|
2022
Q4 | $371K | Sell |
5,468
-223
| -4% | -$15.1K | 0.03% | 242 |
|
|
2022
Q3 | $312K | Buy |
5,691
+517
| +10% | +$28.3K | 0.04% | 237 |
|
|
2022
Q2 | $342K | Buy |
5,174
+351
| +7% | +$23.2K | 0.04% | 291 |
|
|
2022
Q1 | $320K | Buy |
+4,823
| New | +$320K | 0.03% | 314 |
|